The Clinic: CBDs Kill Leukemia Cells
Last week, word leaked that GW Pharmaceuticals will supply the US government with cannabis-derived cannabidiol (CBD) for a special Investigative New Drug program, so at least 50 children with epilepsy can try the non-psychoactive marijuana-derived compound as a way to control seizures and treat their disease.
Now, a GW-funded study published in the journal Anticancer Research has shown that cannabinoids – “the bioactive components of the cannabis plant that display a diverse range of therapeutic qualities” — can kill cancerous cells related to leukemia. Read more
Latest posts by Stephen Carter (see all)
- Central Texas Candidate for Congress Takes Bold Stance on Marijuana Policy - September 17, 2017